Apotheek Sorgeloose: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Sorgeloose
Largest movements
- Cash -€16,220
down €16,220 (-74.2%), from €21,869 to €5,649
mainly Other debts (-€13,656) and Net result for the year (-€3,389)
- Other debts -€13,656
down €13,656 (-14.5%), from €93,925 to €80,268
- Profit (loss) carried forward -€3,389
down €3,389 (-3.6%), from -€94,476 to -€97,864
- Trade debts +€860
up €860 (+36.1%), from €2,385 to €3,245
- Other operating charges -€17,504
down €17,504 (-94.6%), from €18,503 to €999
- Gross operating margin -€8,902
down €8,902, from €6,565 to -€2,338
- Depreciation -€172
no longer reported in 2025 (was €172)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €21,869 | €5,649 | -€16,220 | -74.2% |
| Current assets | 29/58 | €21,869 | €5,649 | -€16,220 | -74.2% |
| Cash at bank and in hand | 54/58 | €21,869 | €5,649 | -€16,220 | -74.2% |
| Total equity and liabilities | 10/49 | €21,869 | €5,649 | -€16,220 | -74.2% |
| Equity | 10/15 | -€74,476 | -€77,864 | -€3,389 | -4.5% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€94,476 | -€97,864 | -€3,389 | -3.6% |
| Amounts payable | 17/49 | €96,345 | €83,513 | -€12,832 | -13.3% |
| Amounts payable within one year | 42/48 | €96,345 | €83,513 | -€12,832 | -13.3% |
| Trade debts | 44 | €2,385 | €3,245 | +€860 | +36.1% |
| Suppliers | 440/4 | €2,385 | €3,245 | +€860 | +36.1% |
| Taxes, remuneration and social security | 45 | €36 | - | -€36 | |
| Taxes | 450/3 | €36 | - | -€36 | |
| Other amounts payable | 47/48 | €93,925 | €80,268 | -€13,656 | -14.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €172 | - | -€172 | |
| Other operating charges | 640/8 | €18,503 | €999 | -€17,504 | -94.6% |
| Gross operating margin | 9900 | €6,565 | -€2,338 | -€8,902 | |
| Operating profit (loss) | 9901 | -€12,110 | -€3,337 | +€8,774 | +72.4% |
| Financial income | 75/76B | - | €3 | +€3 | |
| Recurring financial income | 75 | - | €3 | +€3 | |
| Financial charges | 65/66B | €102 | €55 | -€47 | -46.0% |
| Recurring financial charges | 65 | €102 | €55 | -€47 | -46.0% |
| Profit (loss) for the period before taxes | 9903 | -€12,212 | -€3,389 | +€8,823 | +72.3% |
| Profit (loss) for the period | 9904 | -€12,212 | -€3,389 | +€8,823 | +72.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€12,212 | -€3,389 | +€8,823 | +72.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.